Search Results - Sheng-Long Ye
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Evaluation of sorafenib in Chinese unresectable hepatocellular carcinoma patients with prior surgery and portal vein tumor thrombosis: A subset analysis of GIDEON study data by Sheng-Long Ye, Xiaoping Chen, Jiamei Yang, Ping Bie, Shuijun Zhang, Fengyong Liu, Luming Liu, Jie Zhou, Kefeng Dou, Christina SM Yip, Xiaolei Yang
Published in Tumor Biology (2017-03-01)Get full text
Article -
4
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements by Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, Jian Zhou, Yi-Hsiang Huang, Shi-Ming Lin, Chung-Kwe Wang, Masafumi Ikeda, Stephen Lam Chan, Su Pin Choo, Shiro Miyayama, Ann Lii Cheng
Published in Liver Cancer (2020-05-01)Get full text
Article -
5
Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15 by Gang Dong, Qiong‐Dan Zheng, Min Ma, Si‐Fan Wu, Rui Zhang, Rong‐Rong Yao, Yin‐Ying Dong, Hui Ma, Dong‐Mei Gao, Sheng‐Long Ye, Jie‐Feng Cui, Zheng‐Gang Ren, Rong‐Xin Chen
Published in Cancer Medicine (2018-03-01)Get full text
Article
